Clinical Trials Logo

Clinical Trial Summary

This clinical trial is a multi centre, randomised, single-blind, parallel group, placebo-controlled, single oral dose study with a positive control arm. Patients previously scheduled for 3rd molar tooth extraction, who are otherwise healthy, will be recruited. Upon completion of surgery, e.g. prior to established pain, patients will be randomised to treatment (SB-706598, placebo or co-codamol) and dosed with the study medication


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00281684
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 2
Start date December 7, 2005
Completion date October 3, 2007

See also
  Status Clinical Trial Phase
Completed NCT02463552 - Naproxen on Tooth Sensitivity Caused by In-office Bleaching N/A
Completed NCT00474175 - Benzocaine Gel Toothache Dose-Response Study Phase 4
Completed NCT04642404 - CBD for Dental Pain Phase 1/Phase 2
Completed NCT00720057 - Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain. Phase 3
Completed NCT02630771 - Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain
Completed NCT00574015 - The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache Phase 4
Recruiting NCT06216951 - Post-Operative Pain After Vital Pulpotomy in Molars With Symptomatic Pulpitis
Completed NCT03153657 - Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching Phase 3
Terminated NCT02862691 - Percocet vs. Bupivicaine for Toothaches in the ED Phase 2